Teenagers are being warned against “heightmaxxing,” a viral trend in which some take erdafitinib—described by outlets as a cancer drug—in an effort to grow taller. Multiple reports say doctors and experts warn that using the medication for height enhancement can be dangerous.
The coverage focuses on the medical risk side of the trend, highlighting that the drug is prescribed for advanced bladder cancer rather than cosmetic height goals. Several outlets also note that there is no reassurance of safety for adolescents and that the medicine is not approved for height enhancement. Some reports add broader context about social or psychological pressures tied to appearance ideals, linking the behaviour to the wider influence of digital-era body image obsessions.
Across outlets, the main agreement is that the trend involves misuse of erdafitinib and that clinicians are warning about severe health risks. Differences are mainly in emphasis: some lead with the urgent warning and medical dangers, while others include additional discussion of appearance pressures and the limits of evidence cited online.
